rs4253211

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000124.4(ERCC6):​c.3689G>C​(p.Arg1230Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0905 in 1,613,988 control chromosomes in the GnomAD database, including 7,410 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1230C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.065 ( 433 hom., cov: 32)
Exomes 𝑓: 0.093 ( 6977 hom. )

Consequence

ERCC6
NM_000124.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.542

Publications

56 publications found
Variant links:
Genes affected
ERCC6 (HGNC:3438): (ERCC excision repair 6, chromatin remodeling factor) This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Alternative splicing occurs between a splice site from exon 5 of this gene to the 3' splice site upstream of the open reading frame (ORF) of the adjacent gene, piggyback-derived-3 (GeneID:267004), which activates the alternative polyadenylation site downstream of the piggyback-derived-3 ORF. The resulting transcripts encode a fusion protein that shares sequence with the product of each individual gene. [provided by RefSeq, Mar 2016]
ERCC6 Gene-Disease associations (from GenCC):
  • Cockayne spectrum with or without cerebrooculofacioskeletal syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Cockayne syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • UV-sensitive syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • UV-sensitive syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 11
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027070343).
BP6
Variant 10-49470271-C-G is Benign according to our data. Variant chr10-49470271-C-G is described in ClinVar as Benign. ClinVar VariationId is 129018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0965 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC6NM_000124.4 linkc.3689G>C p.Arg1230Pro missense_variant Exon 18 of 21 ENST00000355832.10 NP_000115.1 Q03468-1Q59FF6
ERCC6NM_001346440.2 linkc.3689G>C p.Arg1230Pro missense_variant Exon 18 of 21 NP_001333369.1 Q03468-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC6ENST00000355832.10 linkc.3689G>C p.Arg1230Pro missense_variant Exon 18 of 21 1 NM_000124.4 ENSP00000348089.5 Q03468-1

Frequencies

GnomAD3 genomes
AF:
0.0647
AC:
9846
AN:
152124
Hom.:
434
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0204
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0459
Gnomad ASJ
AF:
0.0804
Gnomad EAS
AF:
0.0804
Gnomad SAS
AF:
0.0364
Gnomad FIN
AF:
0.0456
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.0985
Gnomad OTH
AF:
0.0694
GnomAD2 exomes
AF:
0.0712
AC:
17882
AN:
251302
AF XY:
0.0712
show subpopulations
Gnomad AFR exome
AF:
0.0202
Gnomad AMR exome
AF:
0.0352
Gnomad ASJ exome
AF:
0.0764
Gnomad EAS exome
AF:
0.0690
Gnomad FIN exome
AF:
0.0508
Gnomad NFE exome
AF:
0.100
Gnomad OTH exome
AF:
0.0787
GnomAD4 exome
AF:
0.0931
AC:
136149
AN:
1461746
Hom.:
6977
Cov.:
33
AF XY:
0.0916
AC XY:
66580
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0180
AC:
602
AN:
33472
American (AMR)
AF:
0.0384
AC:
1716
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0776
AC:
2029
AN:
26132
East Asian (EAS)
AF:
0.101
AC:
4012
AN:
39692
South Asian (SAS)
AF:
0.0425
AC:
3663
AN:
86246
European-Finnish (FIN)
AF:
0.0547
AC:
2921
AN:
53418
Middle Eastern (MID)
AF:
0.0945
AC:
545
AN:
5768
European-Non Finnish (NFE)
AF:
0.104
AC:
115607
AN:
1111906
Other (OTH)
AF:
0.0837
AC:
5054
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
6862
13724
20585
27447
34309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4222
8444
12666
16888
21110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0646
AC:
9837
AN:
152242
Hom.:
433
Cov.:
32
AF XY:
0.0602
AC XY:
4480
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0203
AC:
845
AN:
41552
American (AMR)
AF:
0.0459
AC:
702
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0804
AC:
279
AN:
3470
East Asian (EAS)
AF:
0.0801
AC:
415
AN:
5184
South Asian (SAS)
AF:
0.0365
AC:
176
AN:
4826
European-Finnish (FIN)
AF:
0.0456
AC:
483
AN:
10598
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.0985
AC:
6698
AN:
67998
Other (OTH)
AF:
0.0672
AC:
142
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
468
936
1403
1871
2339
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0822
Hom.:
436
Bravo
AF:
0.0632
TwinsUK
AF:
0.107
AC:
397
ALSPAC
AF:
0.108
AC:
417
ESP6500AA
AF:
0.0209
AC:
92
ESP6500EA
AF:
0.0962
AC:
827
ExAC
AF:
0.0731
AC:
8879
EpiCase
AF:
0.0955
EpiControl
AF:
0.0952

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 13, 2012
Claritas Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 15, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

COFS syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cockayne syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
9.6
DANN
Benign
0.89
DEOGEN2
Benign
0.13
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.36
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.54
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.18
Sift
Benign
0.14
T
Sift4G
Benign
0.30
T
Polyphen
0.0010
B
Vest4
0.12
MPC
0.15
ClinPred
0.0048
T
GERP RS
-7.1
Varity_R
0.22
gMVP
0.28
Mutation Taster
=71/29
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4253211; hg19: chr10-50678317; COSMIC: COSV63388691; API